These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20960796)

  • 21. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcomes in congenital adrenal hyperplasia.
    Cheng TQ; Speiser PW
    Adv Pediatr; 2012; 59(1):269-81. PubMed ID: 22789582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of 17alpha-hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage.
    Török D; Mühl A; Votava F; Heinze G; Sólyom J; Crone J; Stöckler-Ipsiroglu S; Waldhauser F
    Clin Chem; 2002 Feb; 48(2):370-2. PubMed ID: 11805024
    [No Abstract]   [Full Text] [Related]  

  • 24. [Do we need congenital adrenal hyperplasia screening for premature infants?].
    Huet F; Godefroy A; Cheillan D; Somma C; Roussey M
    Arch Pediatr; 2014 Feb; 21(2):233-6. PubMed ID: 24361036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of 17 alpha-hydroxyprogesterone in dried blood spots for mass screening of newborn infants with congenital adrenal hyperplasia.
    Mardesić D; Dumić M; Tajić M; Gjurić G; Letica-Protega N
    Acta Med Iugosl; 1983; 37(2):95-100. PubMed ID: 6880831
    [No Abstract]   [Full Text] [Related]  

  • 26. How reliable is newborn screening for congenital adrenal hyperplasia?
    Pass KA
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):74-5. PubMed ID: 16932259
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ; Oudshoorn CG; Elvers BH; van Baarle M; Otten BJ; Wit JM; Verkerk PH
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3904-7. PubMed ID: 15797960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM; Abad LR; Cua SC; Domingo CF
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible andrologic markers in elevated neonatal 17-hydroxyprogesterone.
    Cavarzere P; Vincenzi M; Gaudino R; Franceschi R; Perlini S; Camilot M; Teofoli F; Antoniazzi F; Tatò L
    Fertil Steril; 2010 Nov; 94(6):2350-2. PubMed ID: 20537623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
    J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [17-Hydroxyprogesterone].
    Watanabe F
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():471-3. PubMed ID: 8753283
    [No Abstract]   [Full Text] [Related]  

  • 33. High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia.
    Levy-Shraga Y; Pinhas-Hamiel O
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26912766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S; Dean H; Dent W; Stockl E; Cronin C
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [17 alpha-Hydroxyprogesterone].
    Shimizu Y; Yanaihara T
    Nihon Rinsho; 1999 Dec; 57 Suppl():170-2. PubMed ID: 10778091
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of the first newborn screening program in the People's Democratic Republic of Laos.
    Hoehn T; Lukacs Z; Stehn M; Mayatepek E; Philavanh K; Bounnack S
    J Trop Pediatr; 2013 Apr; 59(2):95-9. PubMed ID: 23104563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring medical treatment in adolescents and young adults with congenital adrenal hyperplasia: utility of salivary 17α-hydroxyprogesterone day profiles.
    Deutschbein T; Unger N; Hauffa BP; Schaaf K; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Mar; 119(3):131-8. PubMed ID: 20690075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Partial 3ß-hydroxysteroid dehydrogenase type 2 deficiency: Diagnosis of a novel mutation after positive newborn screening for 21-hydroxylase deficiency].
    Bahíllo-Curieses MP; Loidi Fernández de Trocóniz L; del Cañizo López A; Martínez-Sopena MJ
    Med Clin (Barc); 2016 Jan; 146(2):92-3. PubMed ID: 26021573
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.